avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata4
|
ENSMUSG00000021944.9 | GATA binding protein 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gata4 | mm10_v2_chr14_-_63271682_63271702 | 0.32 | 5.9e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 23.2 | GO:0002215 | defense response to nematode(GO:0002215) |
4.8 | 38.6 | GO:0015671 | oxygen transport(GO:0015671) |
4.8 | 14.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
4.3 | 38.7 | GO:0002432 | granuloma formation(GO:0002432) |
3.9 | 23.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
3.1 | 18.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.9 | 8.8 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
2.0 | 5.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.9 | 19.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.8 | 5.5 | GO:0015866 | ADP transport(GO:0015866) |
1.8 | 16.1 | GO:0032264 | IMP salvage(GO:0032264) |
1.7 | 5.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.7 | 18.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
1.6 | 11.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.4 | 11.5 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.4 | 6.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.4 | 21.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.4 | 10.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.3 | 22.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) glycolipid catabolic process(GO:0019377) |
1.3 | 5.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
1.3 | 8.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.2 | 15.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
1.1 | 4.5 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.1 | 42.3 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
1.0 | 4.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.0 | 5.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.0 | 5.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.0 | 8.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.9 | 17.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.9 | 10.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 2.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.8 | 10.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.7 | 2.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 11.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 16.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 5.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 13.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.6 | 1.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 14.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.5 | 8.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 2.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 7.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.5 | 2.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.5 | 4.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 1.5 | GO:0060796 | stem cell fate specification(GO:0048866) regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) regulation of cardiac cell fate specification(GO:2000043) |
0.5 | 18.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.5 | 2.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 2.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.4 | 16.6 | GO:0032094 | response to food(GO:0032094) |
0.4 | 2.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 24.9 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.4 | 4.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 15.0 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.3 | 1.0 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 2.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 1.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 5.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 0.5 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.2 | 7.7 | GO:0009409 | response to cold(GO:0009409) production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.2 | 6.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 5.6 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 2.8 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 5.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 6.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 1.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 6.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 10.5 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.1 | 2.8 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 2.9 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.7 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 2.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 8.4 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 1.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 6.5 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 4.0 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 1.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 14.0 | GO:0006887 | exocytosis(GO:0006887) |
0.0 | 61.8 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 5.8 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.0 | 2.2 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.0 | 1.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 2.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 38.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.6 | 39.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.9 | 11.6 | GO:0032437 | cuticular plate(GO:0032437) |
1.5 | 22.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.3 | 5.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.7 | 5.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 13.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 20.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 11.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 10.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 2.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 10.7 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 7.6 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 14.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 2.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 16.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 18.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 156.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 9.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 9.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 9.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 12.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 5.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 3.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 5.5 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 5.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 3.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 6.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 3.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 6.3 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 2.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 24.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 45.3 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 24.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
4.8 | 38.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
4.2 | 46.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
3.3 | 23.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.2 | 8.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.9 | 5.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.9 | 9.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.8 | 58.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.8 | 16.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.8 | 8.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.6 | 14.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.5 | 22.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.4 | 6.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 10.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 11.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.2 | 5.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 2.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.9 | 7.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 5.1 | GO:1902282 | phosphorelay sensor kinase activity(GO:0000155) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.8 | 4.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.7 | 2.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.7 | 10.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 3.7 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.6 | 11.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 3.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 3.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.5 | 6.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 13.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.5 | 5.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.5 | 94.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 5.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 4.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 4.5 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.3 | 1.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 17.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.3 | 2.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 11.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 4.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 10.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 40.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 10.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 2.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 17.1 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 6.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 2.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 5.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 11.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 3.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 17.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 6.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 5.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 5.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 2.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 1.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 11.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 9.2 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 1.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 22.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 47.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 10.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 11.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 8.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 8.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 5.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 16.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 33.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 9.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.7 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 18.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 16.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 15.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.8 | 23.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 14.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 13.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 5.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 11.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 10.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 7.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 9.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 6.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 8.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 5.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 5.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 4.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 6.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |